Antibiotic 1166C

Modify Date: 2025-08-25 19:17:26

Antibiotic 1166C Structure
Antibiotic 1166C structure
Common Name Antibiotic 1166C
CAS Number 83329-73-1 Molecular Weight 690.86100
Density N/A Boiling Point N/A
Molecular Formula C38H58O11 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Antibiotic 1166C


Hygrolidin is a 16-membered macrolide antibiotic produced by Streptomyces hygroscopicus D-1166. Hygrolidin has anti-fungus activity against Valsa ceratosperma. Hygrolidin induces p21 expression and abrogates cell cycle progression at G1 and S phases. Hygrolidin has antitumor activity[1][2][3].

 Names

Name hygrolidin

 Antibiotic 1166C Biological Activity

Description Hygrolidin is a 16-membered macrolide antibiotic produced by Streptomyces hygroscopicus D-1166. Hygrolidin has anti-fungus activity against Valsa ceratosperma. Hygrolidin induces p21 expression and abrogates cell cycle progression at G1 and S phases. Hygrolidin has antitumor activity[1][2][3].
Related Catalog
In Vitro Hygrolidin (0.1, 1 μg/ml; for 24 h) increases both G1 and S phase populations and decreases M phase population[1]. Hygrolidin (0.1, 1, 10 μg/ml; for 24 h) decreases the amounts of cdk4, cyclin D, cyclin B and increases the amounts of cyclin E and p21. Hygrolidin-induced p21 preferentially associates with cyclin A-cdk2 complex and inhibits it[1]. Hygrolidin (0.1, 1 μg/ml; for 24 h) selectively induces p21 in DLD-1 cells at mRNA level, but not in WI-38 fibroblasts[1]. Hygrolidin, for 3 days, inhibits growth of various cell lines including DLD-1 colon cancer, LNCaP prostate cancer, K562 leukemia cells, LNCaP prostate cancer, EL-4 lymphoma (IC50s = 1.0-33 ng/ml, respectively)[1]. Hygrolidin shows growth inhibition on Trypanosoma cruzi (IC50=1.1 nM), Trypanosoma brucei brucei (IC50=77 nM), and Leishmania donovani (IC50=72.5 nM)[3]. Cell Cycle Analysis[1] Cell Line: DLD-1 cells Concentration: 0.1, 1 μg/ml Incubation Time: For 24 hours Result: Increased both G1 and S phase populations and decreased M phase population. Western Blot Analysis[1] Cell Line: DLD-1 cells Concentration: 0.1, 1, 10 μg/ml Incubation Time: For 24 hours Result: Decreased the amounts of cdk4, cyclin D, cyclin B and increased the amounts of cyclin E and p21. RT-PCR[1] Cell Line: DLD-1 or WI-38 cells Concentration: 0.1, 1 μg/ml Incubation Time: For 24 hours Result: Selectively induced p21 in DLD-1 cells at mRNA level, but not in WI-38 fibroblasts.
References

[1]. Manabu Kawada, et al. Hygrolidin induces p21 expression and abrogates cell cycle progression at G1 and S phases. Biochem Biophys Res Commun. 2002 Oct 18;298(1):178-83.

[2]. H Seto, et al. The isolation and structures of hygrolidin amide and defumarylhygrolidin. J Antibiot (Tokyo). 1984 May;37(5):610-3.

[3]. F Annang, et al. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease. J Biomol Screen. 2015 Jan;20(1):82-91.

 Chemical & Physical Properties

Molecular Formula C38H58O11
Molecular Weight 690.86100
Exact Mass 690.39800
PSA 169.05000
LogP 5.05440
InChIKey UGIOXKVQFJIRMZ-HRNPMOGOSA-N
SMILES CCC1OC(O)(C(C)C(O)C(C)C2OC(=O)C(C)=CC(C)=CC(C)C(O)C(C)CC(C)=CC=CC2OC)CC(OC(=O)C=CC(=O)O)C1C
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Antibiotic 1166C suppliers

Antibiotic 1166C price

Related Compounds: More...
2-[3-(diaminomethylideneamino)-4-(3,4-dihydroxy-4,5-dimethyloxolan-2-yl)oxy-2,5,6-trihydroxycyclohexyl]guanidine
99890-21-8
A201A
37305-78-5
antibiotic AS 40
80701-06-0
Antibiotic TS 155-2
303009-07-6
sodium,(5R,6R)-3-[(E)-2-acetamidoethenyl]sulfanyl-6-ethyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
73573-25-8
Antibiotic A 83586C
116364-81-9
N-[(E)-2-[(14E)-9-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-7-hydroxy-2,8,12,16-tetramethyl-5,13-dioxo-4,17-dioxabicyclo[14.1.0]heptadec-14-en-10-yl]ethylideneamino]acetamide
130812-04-3
Antibiotic-5d
251349-54-9
methyl 4-[5-(4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
79638-26-9
4-(benzyloxy)-N-methylbenzene-1-sulfonamide
2001360-77-4
4-cyclopropyl-N-propylbenzene-1-sulfonamide
2016279-53-9
9-Methyl-1-(1,1,1-trifluoropropan-2-yl)-1,7-diazaspiro[4.5]decane
2171962-20-0
4,4-Difluoro-1-[1-(4-methyl-1,3-thiazol-2-yl)pyrrolidine-3-carbonyl]piperidine
2877669-52-6
Dimethyl(2-{8-methyl-1,7-diazaspiro[4.5]decan-1-yl}ethyl)amine
2168394-45-2
1-Cyclopropyl-8-methyl-1,7-diazaspiro[4.5]decane
2167093-49-2
5-Chloro-2-[3-(4,4-difluoropiperidine-1-carbonyl)pyrrolidin-1-yl]-3-fluoropyridine
2877639-20-6
1-(1-Cyclopropylethyl)-8-methyl-1,7-diazaspiro[4.5]decane
2167010-33-3
N-benzyl-5-(bromomethyl)-4-methyl-4,5-dihydro-1,3-thiazol-2-amine
2649056-09-5
5-(bromomethyl)-N-[(3-chlorophenyl)methyl]-4-methyl-4,5-dihydro-1,3-thiazol-2-amine
2649068-47-1